Hyeon Gu Kang

Jackson Laboratory — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

2h-index36citations23works8.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

DNA Repair Mechanisms(17), PARP inhibition in cancer therapy(16), Genetics and Neurodevelopmental Disorders(14), CRISPR and Genetic Engineering(2), Single-cell and spatial transcriptomics(2)

Publications23 total

Host-specific bacterial modulation of airway gene expression and alternative splicing
mSphere·2025Open Access
SpliceDecoder: A High-Throughput Tool for Guiding the Functional Interpretation of Differential Splicing Events
2025· 1 citedOpen Access
Host-specific bacterial modulation of airway gene expression and alternative splicing
2025Open Access
Comprehensive single-cell aging atlas of healthy mammary tissues reveals shared epigenomic and transcriptomic signatures of aging and cancer
Nature Aging·2024· 33 citedOpen Access
Comprehensive single cell aging atlas of mammary tissues reveals shared epigenomic and transcriptomic signatures of aging and cancer
2023· 2 citedOpen Access
Supplementary Data from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
2023Open Access
Supplementary Figure from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
2023Open Access
Data from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
2023Open Access
Supplementary Data from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
2023Open Access
Supplementary Data from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
2023Open Access
Supplementary Data from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
2023Open Access
Supplementary Data from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
2023Open Access
Supplementary Data from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
2023Open Access
Supplementary Data from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
2023Open Access
Supplementary Data from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
2023Open Access
Supplementary Data from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
2023Open Access
Supplementary Data from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
2023Open Access
Supplementary Figure from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
2023Open Access
Supplementary Data from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
2023Open Access
Data from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response
2023Open Access
page 1 of 2Next →

Frequent Co-authors

Haeun Hwangbo(17), Myung Ji Kim(17), Sinae Kim(17), Jae‐Weon Kim(17), Byoung‐Gie Kim(17), Eun‐Hae Cho(17), Suhwan Chang(17), Jung‐Yun Lee(17), Jung Kyoon Choi(17), Min Ji Park(16), Eun Ji Lee(12), Olga Anczuków(5), Karolina Palucka(4), Eun Ji Lee(4), Jeffrey H. Chuang(3), Brittany Angarola(2), Siddhartha Sharma(2), Neerja Katiyar(2), Djamel Nehar-Belaid(2), Sung‐Hee Park(2)